Nifty hovers around 15,900 mark; Call writers spotted writing call options aggressively between 15,900-16,000 strike price!
Nifty hovers around 15,900 mark; Call writers spotted writing call options aggressively between 15,900-16,000 strike price!

Nifty hovers around 15,900 mark; Call writers spotted writing call options aggressively between 15,900-16,000 strike price!

Karan Dsij Article rating: 4.1

Options data does point out that the 15,900-16,000 is likely to act as a crucial barrier for the index in the near term as nearly 59 lakh shares combinedly have been added in between 15,900-16,000 call strikes.   

Five stocks witnessing long built-up
Five stocks witnessing long built-up

Five stocks witnessing long built-up

Ganesh Pawar Article rating: 3.6

The market opened in green on July 16, 2021, overall volumes in futures & options currently stand at 9,57,63,406 contracts with a turnover of Rs. 93,17,900.34 crore.

Five stocks witnessing short built-up
Five stocks witnessing short built-up

Five stocks witnessing short built-up

Ganesh Pawar Article rating: 3.6

The market opened in green on July 16, 2021, overall volumes in futures & options currently stand at 9,57,63,406 contracts with a turnover of Rs. 93,17,900.34 crore.

T20 breakout stocks: Best swing trading stocks to keep an eye on!
T20 breakout stocks: Best swing trading stocks to keep an eye on!

T20 breakout stocks: Best swing trading stocks to keep an eye on!

Karan Dsij Article rating: 3.3

Interestingly, a lot of names have come up from the IT space, which includes large-cap as well as mid and small-cap companies; hence, this sector could be in the limelight in the coming days. 

Sequent Scientific climbs over 7 per cent on receiving EU GMP approval for its tablets
Sequent Scientific climbs over 7 per cent on receiving EU GMP approval for its tablets

Sequent Scientific climbs over 7 per cent on receiving EU GMP approval for its tablets

Abhinav Lahoti Article rating: 3.0

Sequent Scientific Limited announced that it has got European Union good manufacturing practices (EU GMP) approval, which is considered as the highest recognition available by companies in the pharmaceutical space for its tablets dosage manufacturing line in Turkey.

RSS
First18011802180318041806180818091810Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR